跳至主要内容
临床试验/ACTRN12624000865516
ACTRN12624000865516尚未招募Unknown

CanSTEP: Effect of cognitive-motor step exergame training on chemotherapy-induced peripheral neuropathy (CIPN) symptoms in cancer survivors

Dr Jasmine Menant0 个研究点目标入组 178 人开始时间: 2024年7月15日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
178

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • aged 18 years and over;
  • -greater or equal to 6 months and less than 5 years post-completion of neurotoxic chemotherapy treatment for cancer;
  • -no scheduled further neurotoxic cancer treatment;
  • -chemotherapy-induced peripheral neuropathy symptoms impacting lower limbs function;
  • -able to walk 10 metres without the use of a walking aid;
  • -willing and able to comply with all study requirements, including treatment, timing and nature of required assessments
  • -have internet access/Wi-Fi and access to a smart device /computer

排除标准

  • -history of primary brain tumours;
  • -history of metastases (brain or bone) that could affect balance and mobility;
  • -known history of peripheral neuropathy prior to neurotoxic chemotherapy for cancer;
  • -neurological disorders including stroke, Parkinson’s disease, multiple sclerosis, and dementia;
  • -acute psychiatric condition with psychosis;
  • -severe visual impairment;
  • -medical condition precluding balance and stepping exercise;
  • -have insufficient language skills to provide informed consent and fully participate in the program.

研究者

发起方
Dr Jasmine Menant

相似试验